Phase 1 approval for lead chronic pain drug Recruitment to start immediately on company s first human trial Oxford Cannabinoid Technologies (OCT) develops.
<iframe src=https://www.youtube.com/embed/Pe1z4VVzelA></iframe>Oxford Cannabinoid Technologies Holdings PLC Clarissa Sowemimo-Coker tells Proactive s Stephen Gunnion that Medicines and. | May 18, 2023
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) (OTCH) shares rose again after it confirmed recruitment for a phase 1 trial of its lead.
<iframe src=https://www.youtube.com/embed/r0KvbLyxBD0></iframe>Oxford Cannabinoid Technologies Holdings PLC CEO Clarissa Sowemimo-Coker speaks to Proactive after the pharmaceutical group. | April 13, 2023
FTSE 100 Seen Opening Little Changed Ahead of US Inflation Data, Fed Minutes 0629 GMT - The FTSE 100 is expected to open little changed, according to IG, as investors await the release of U.S. inflation data and the Federal Reserve's latest meeting. | 02:55am